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Abstract: It has long been known that the conditionally essential polyunsaturated arachidonic
acid (AA) regulates cerebral blood flow (CBF) through its metabolites prostaglandin E2 and
epoxyeicosatrienoic acid, which act on vascular smooth muscle cells and pericytes to vasorelax cerebral
microvessels. However, AA may also elicit endothelial nitric oxide (NO) release through an increase
in intracellular Ca2+ concentration ([Ca2+]i). Herein, we adopted Ca2+ and NO imaging, combined
with immunoblotting, to assess whether AA induces intracellular Ca2+ signals and NO release in
the human brain microvascular endothelial cell line hCMEC/D3. AA caused a dose-dependent
increase in [Ca2+]i that was mimicked by the not-metabolizable analogue, eicosatetraynoic acid.
The Ca2+ response to AA was patterned by endoplasmic reticulum Ca2+ release through type 3
inositol-1,4,5-trisphosphate receptors, lysosomal Ca2+ mobilization through two-pore channels 1 and
2 (TPC1-2), and extracellular Ca2+ influx through transient receptor potential vanilloid 4 (TRPV4).
In addition, AA-evoked Ca2+ signals resulted in robust NO release, but this signal was considerably
delayed as compared to the accompanying Ca2+ wave and was essentially mediated by TPC1-2 and
TRPV4. Overall, these data provide the first evidence that AA elicits Ca2+-dependent NO release
from a human cerebrovascular endothelial cell line, but they seemingly rule out the possibility that
this NO signal could acutely modulate neurovascular coupling.
Keywords: arachidonic acid; brain microvascular endothelial cells; neurovascular coupling; cerebral
blood flow; Ca2+ signalling; nitric oxide; inositol-1,4,5-trisphosphate receptors; two-pore channels
1-2; transient receptor potential vanilloid 4
1. Introduction
The 20-carbon omega-6 polyunsaturated fatty acid (PUFA) arachidonic acid (AA) is incorporated
in the plasma membrane esterified to phospholipids at the second alcohol of glycerol in the sn-2 position
and exerts multiple homeostatic, structural, and signalling functions [1]. AA is released from the
membrane pool by the activation of three distinct phospholipases, A2, C, and D, upon cell stimulation
to exert either an autocrine and/or a paracrine effect on adjoining cells [1,2]. For instance, synaptically
released glutamate activates N-methyl-d-aspartate receptors (NMDARs), thereby raising intracellular
Ca2+ levels within the dendritic tree and recruiting the Ca2+-dependent enzyme phospholipase A2
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(PLA2). Neuronal PLA2, in turn, mobilizes AA from membrane phospholipids; hereafter, AA is
converted by cyclooxygenase-2 (COX-2) into prostaglandin E2 (PGE2) to relax cerebral microvessels [3].
Likewise, neuronal activity causes an increase in astrocytic Ca2+ concentration, which also recruits
PLA2 to stimulate the synthesis of a number of AA-derived metabolites that serve as vasodilatory
mediators. These include PGE2 and epoxyeicosatrienoic acids (EETs) that are produced by COX-1 and
cytochrome P450 epoxygenase [2,4], respectively. Alternately, astrocyte-derived AA is released onto
neighbouring vascular smooth muscle cells (VSMCs) or pericytes where it can be metabolized into the
vasoconstrictor 20-hydroxyeicosatetraenoic acid (20-HETE) by cytochrome P450 4A2 [2,4–6]. AA is
thus regarded as a key regulator of neurovascular coupling (NVC), the mechanism whereby neuronal
activity results in the elevation of local cerebral blood flow (CBF), which is indispensable to maintain
proper supply of oxygen and nutrients to active brain regions [2–4,7]. For instance, the hemodynamic
response to whisker stimulation in the somatosensory cortex was dramatically impaired by inhibiting
the production of PGE2 and EETs by, respectively, pyramidal neurons and astrocytes [8]. Conversely,
only EETs were responsible for the elevation in CBF evoked by stimulation of basal forebrain cholinergic
neurons [9]. On the other hand, 20-HETE has been shown to induce capillary vasoconstriction in both
the molecular [10] and granular [5] layer of the cerebellum, depending on the presence of nitric oxide
(NO), that suppresses cytochrome P450 4A2 activity [2].
A recent series of studies demonstrated that cerebral endothelial cells, which line the lumen of
brain microvessels and are in close apposition to both astrocyte end-feet and neuronal projections within
the neurovascular unit, may also translate neuronal activity into NO-dependent vasodilation [11–13].
For instance, the neurotransmitter acetylcholine triggers a biphasic increase in intracellular Ca2+
concentration ([Ca2+]i) which leads to the recruitment of Ca2+/calmodulin (CaM)-sensitive endothelial
NO synthase (eNOS) in hCMEC/D3 cells [14], which are a widely utilized human brain microvascular
endothelial cell line [15]. Likewise, acetylcholine and glutamate were found to induce repetitive
oscillations in [Ca2+]i and NO production in mouse brain microvascular endothelial cells [14,16]. The
Ca2+ response to extracellular neurotransmitters in cerebrovascular endothelial cells is mainly mediated
by inositol-1,4,5-trisphosphate (InsP3) receptors (InsP3Rs) and two-pore channels 1 and 2 (TPC1-2),
which mediate Ca2+ release from endoplasmic reticulum (ER) and lysosomes, respectively, and by
store-operated Ca2+ entry (SOCE), a widespread Ca2+-permeable route activated following depletion
of the ER Ca2+ reservoir [14,16,17]. Intriguingly, it has long been known that AA directly induces
Ca2+-dependent NO release in vascular endothelial cells [18–21] and endothelial colony-forming
cells (ECFCs) [22]. The Ca2+ response to AA is shaped by multiple components of the endothelial
Ca2+ toolkit, including InsP3Rs and TPC1, which mediate endogenous Ca2+ release, respectively, and
transient receptor potential vanilloid 4 (TRPV4), which mediates extracellular Ca2+ influx [18–21,23].
Conversely, AA is seemingly unable to activate SOCE [24–26]. A recent investigation suggested that
AA may be converted by cytochrome P450 2U1 epoxygenase into 20-HETE also in hCMEC/D3 cells
and rat brain microvessels [27]. Furthermore, a preliminary report showed that AA may trigger
intracellular Ca2+ signals in primary human brain microvascular endothelial cells, but the underlying
signalling pathway was not clearly elucidated and their ability to promote NO was not evaluated [23].
Herein, we investigated for the first time whether and how exogenous AA induces intracellular
Ca2+ signalling and NO release in hCMEC/D3 cells. AA elicited a biphasic increase in [Ca2+]i which
was shaped by endogenous Ca2+ release through type 3 inositol-1,4,5-trisphosphate receptor isoform
(InsP3R3) and two-pore channels 1 and 2 (TPC1-2) and extracellular Ca2+ influx through TRPV4.
We further demonstrated that AA induced robust Ca2+-dependent NO release. However, AA-induced
NO production was remarkably delayed as compared to intracellular Ca2+ signalling. In addition,
AA-induced NO release was mainly dependent upon TPC1-2 and TRPV4 activation rather than InsP3R3.
Overall, these data provide the evidence that AA is able to induce intracellular Ca2+ signalling and
NO release in human brain microvascular endothelial cells, although this NO release is seemingly too
slow to account for the vasorelaxing effects of AA observed in vivo.
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2. Materials and Methods
2.1. Cell Culture
Human cerebral microvascular endothelial cells (hCMEC/D3) were obtained from Institut National
de la Santé et de la Recherche Médicale (INSERM, Paris, France) and cultured as extensively illustrated
elsewhere [17]. Only hCMEC/D3 cells between passage 25 and 35 were employed in the present
investigation. The cells were seeded at a concentration of 27,000 cells/cm2 and grown in tissue
culture flasks coated with 0.1 mg/mL rat tail collagen type 1, in a medium having the following
composition: EBM-2 medium (Lonza, Basel, Switzerland) supplemented with 5% foetal bovine serum,
1 ng/mL basic fibroblast growth factor, 1% penicillin–streptomycin, 5 µg/mL ascorbic acid, 1.4 µM
hydrocortisone, 1/100 chemically defined lipid concentrate (Life Technologies, Milan, Italy), and 10 mM
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES). The cells were cultured at 37 ◦C, 5% CO2
saturated humidity.
2.2. Solutions
The composition of the physiological salt solution (PSS) used to load the cells with the Ca2+- and
NO-sensitive dyes and to bath the cells during recordings had the following composition: 150 mM
NaCl, 6 mM KCl, 1.5 mM CaCl2, 1 mM MgCl2, 10 mM glucose, and 10 mM HEPES. In order to obtain
an extracellular solution devoid of Ca2+ (0Ca2+), Ca2+ was substituted with 2 mM NaCl and 0.5 mM
EGTA was added. Solutions were titrated to pH 7.4 with NaOH. The osmolality of PSS was measured
with an osmometer (Wescor 5500, Wescor, Logan, UT, USA) and resulted to be 300–310 mOsm/L.
2.3. [Ca2+]i and NO Imaging
Ca2+ imaging was carried out as described elsewhere [17]. Briefly, hCMEC/D3 cells were loaded
with 4 µM Fura-2 acetoxymethyl ester (Fura-2/AM; 1 mM stock in dimethyl sulfoxide) in PSS. The cells
were maintained in the presence of Fura-2 for 30 min at 37 ◦C and 5% CO2 saturated humidity.
After de-esterification in PSS, the coverslip (8 mm) was mounted on the bottom of a Petri dish
and the cells observed by an upright epifluorescence Axiolab microscope (Carl Zeiss, Oberkochen,
Germany) equipped with a Zeiss ×40 Achroplan objective (water immersion, 2.0 mm working distance,
0.9 numerical aperture). The cells were excited alternately at 340 and 380 nm by using a filter wheel
(Lambda 10, Sutter Instrument, Novato, CA, USA). The emitted fluorescence was detected at 510 nm
by using an Extended-ISIS CCD camera (Photonic Science, Millham, UK). Custom-made software,
working in the LINUX environment, was used to drive the CCD camera and the filter wheel, and
to measure and plot on-line the fluorescence from 15 to 25 rectangular “regions of interest” (ROI),
each corresponding to well defined single cells. [Ca2+]i was monitored by measuring, for each ROI,
the ratio of the mean fluorescence emitted at 510 nm when exciting alternatively at 340 and 380 nm
(Ratio (F340/F380)). An increase in [Ca2+]i causes an increase in the ratio [17]. Ratio measurements
were performed and plotted on-line every 3 s. The experiments were performed at room temperature
(22 ◦C), as discussed in [28].
NO was measured as described in [17]. Briefly, hCMEC/D3 cells were loaded with the membrane
permeable NO-sensitive dye 4-amino-5-methylamino-2’,7’-difluorofluorescein (DAF-FM) diacetate
(10 µM) in PSS. The cells were maintained in the presence of DAF-FM for 1 h at 37 ◦C and 5% CO2
saturated humidity. Subsequently, the dye was de-esterified in PSS for a further hour. DAF-FM
fluorescence was measured by using the same equipment described for Ca2+ recordings but with a
different filter set, i.e., excitation at 480 nm and emission at 535 nm wavelength (emission intensity
was shortly termed “NOi”). The changes in DAF-FM fluorescence induced by AA were recorded
and plotted on-line every 5 s. Again, off-line analysis was performed by using custom-made macros
developed by Microsoft Office Excel software. The experiments were performed at room temperature
(22 ◦C).
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2.4. Western Blotting
Semi-confluent adherent cells were carefully lysate by using ice-cold RIPA buffer (150 mM NaCl,
25 mM Tris-HCl pH 7.6, 1% sodium deoxycholate, 1% NP-40, and 0.1% SDS) adding protease inhibitor
cocktail (Sigma-Aldrich, Milan, Italy). In order to determine the protein concentration, a bicinchoninic
acid kit (Thermo Fisher Scientific, Waltham, MA, USA) was used following the manufacturer’s
instructions. Antibodies against TRPV4 (ab94868; Abcam, Cambridge, UK) and antibodies anti–β-actin
(Sigma-Aldrich) were used as indicated by the manufacturer. Chemiluminescence assays were
conducted by using western blotting plus ECL (Perkin Elmer, Milano, Italy).
2.5. Statistical Analysis
All the data were obtained from hCMEC/D3 cells from no fewer than three independent
experiments. The peak amplitude of AA-evoked Ca2+ signals was measured as the difference
between the ratio at the Ca2+ peak and the mean ratio of 30 sec baseline before the peak. The dose–
response relationship was fitted by using the following equation:
Y =
100
1+ EC50
[AA]
(1)
where Y is the amplitude of the Ca2+ response, [AA] is the AA concentration, and EC50 is the
half-maximal effective concentration, i.e., the [AA] that elicited 50% of the maximal response.
The peak amplitude of AA-induced NO production was evaluated as the difference between the
maximal increase in DAF-FM fluorescence and the average of 1 min baseline before the peak. Pooled
data are given as average± standard error (SE) and statistical significance (p < 0.05) was evaluated by
two-tailed Student’s t test for unpaired observations or one-way ANOVA analysis followed by the
post-hoc Dunnett’s test as appropriate. Data relative to both Ca2+ and NO signals are summarized as
mean ± SE, whereas the number of cells analysed for each condition is indicated in the corresponding
bar histograms.
2.6. Chemicals
Fura-2/AM and DAF-FM were purchased from Molecular Probes (Molecular Probes Europe
BV, Leiden, The Netherlands). GSK1016790A (GSK) was obtained from Tocris (Bristol, UK). All the
chemicals were of analytical grade and obtained from Sigma Chemical Co. (St. Louis, MO, USA).
3. Results
3.1. AA Triggers an Increase in [Ca2+]i in hCMEC/D3 Cells
In order to assess whether AA induces intracellular Ca2+ signals, hCMEC/D3 cells were loaded
with the Ca2+-sensitive fluorophore, Fura-2, as described in paragraph 2.3. Neuronal activity leads to
remarkable increase in synaptic AA concentration, which can rise up to 50–200 µM [29–31]. Accordingly,
AA induced an increase in [Ca2+]i in hCMEC/D3 cells that started at 1 µM (Figure 1A), reached the
maximal response at 300 µM, and whose dose–response relationship could be fitted by a sigmoidal
curve with an EC50 of 8.4 µM (Figure 1B). A careful inspection of the Ca2+ traces revealed that 3 µM
AA elicited a slow elevation in [Ca2+]i that remained stable during the continuous presence of the
agonist in the bath (Figure 1A). Conversely, when applied at 30 µM and 300 µM, AA induced a rapid
Ca2+ transient that slowly decayed to a sustained plateau of elevated [Ca2+]i (Figure 1A), as recently
shown in ECFCs [22].
As synaptic AA concentration may achieve the mid-to-high micromolar range [29–31], we used
30 µM AA throughout the remainder of the study. The Ca2+ response to AA (30 µM) was reversible as,
when AA was removed from the bath at the peak of the Ca2+ rise, the [Ca2+]i rapidly returned to the
baseline, whereas the subsequent addition of AA raised intracellular Ca2+ levels again (Figure 1C).
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AA-induced endothelial Ca2+ signals may be triggered by many of its derivatives, such as 5,6-
epoxyeicosatrienoic (5,6-EET) and 8,9-EET and leukotriene C4, which are synthesized, respectively, by
cytochrome P450 epoxygenase and glutathione S-transferase 2 [32–36]. Therefore, we evaluated the
Ca2+ response to the non-metabolized AA analogue, eicosatetraynoic acid (ETYA), as described in
other types of endothelial cells [22,37]. As shown in Figure 2, ETYA (30 µM) induced an increase in
[Ca2+]i whose kinetics and amplitude were similar to those of the Ca2+ signal induced by AA (30 µM)
in the same batches of hCMEC/D3 cells (Figure 2A,B). Taken together, these findings demonstrate that
AA has no need to be metabolized to induce intracellular Ca2+ signals in human brain microvascular
endothelial cells.
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Figure 1. Arachidonic acid (AA) induces an increase in intracellular Ca2+ concentration ([Ca2+]i) in
hCMEC/D3 cells. (A) Intracellular Ca2+ signals evoked by increasing doses of AA in the hCMEC/D3
cell line. In this and the following figures, agonists and drugs were administered as indicated by
the horizontal bars above the traces. (B) Dose–response relationship of the amplitude of AA-evoked
Ca2+ signals in hCMEC/D3 cells. The continuous line was obtained from a fit to a sigmoidal
concentration-response curve by using Equation (1). (C) 30 µM AA evoked a rapid increase in [Ca2+]i
that decayed to the baseline upon agonist removal from the perfusate. When AA was re-added at
the same dose, it induced a second elevation in [Ca2+]i that achieved the same peak amplitude as the
first one.
3.2. AA-Induced Intracellular Ca2+ Signals Required Endogenous Ca2+ Release and Extracellular Ca2+ Influx
As mentioned earlier, AA-induced endothelial Ca2+ signals impinge on endogenous Ca2+ release
and extracellular Ca2+ influx [18–21]. In order to address is issue, we evaluated the Ca2+ response
to AA in hCMEC/D3 cells in the absence of extracellular Ca2+ (0Ca2+), after which xtracellular Ca2+
was restituted while maintaining the agonist in the perfusate. Under 0Ca2+ cond tion , 30 µM AA
induced a transient elevation in [Ca2+]i, which was due to Ca2+ mobilizatio from the intracellular
stores, whereas reintroduction of external Ca2+ caused a second intracellular Ca2+ wave (Figure 3A),
which was sustained by extracellular Ca2+ influx [22].
The same results were obtained when AA concentration was raised up to 50 µM (Figure 3B).
As expected [22], endogenous Ca2+ release and extracellular Ca2+ influx were significantly (p < 0.05)
higher at the highest AA concentration (Figure 3C). Overall, these findings demonstrate that intracellular
Ca2+ release and extracellular Ca2+ influx mediate AA-evoked Ca2+ signals in hCMEC/D3 cells.
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Figure 2. Arachidonic acid (AA) metabolism is not necessary for arachidonic acid-induced elevation in
[Ca2+]i in hCMEC/D3 cells. (A) 30 µM eicosatetraynoic acid (ETYA), a non-metabolizable analogue
of AA, elicits an intracellular Ca2+ signal which overlaps with the Ca2+ response to 30 µM AA in
hCMEC/D3 cells. (B) Mean ± SE of the amplitude of ETYA- and AA-induced elevations in [Ca2+]i.Cells 2019, 8, x 7 of 20 
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Figure 3. Arachidonic acid induces endogenous Ca2+ release and extracellular Ca2+ influx in hCMEC/D3
cells. (A) 30 µM AA evoked endogenous Ca2+ release under absence of extracellular Ca2+ (0Ca2+)
conditions followed by a second increase in [Ca2+]i upon Ca2+ restitution to the bath in the continuous
presence of the agonist. (B) 50 µM AA evoked endogenous Ca2+ release under 0Ca2+ conditions
followed by a second increase in [Ca2+]i upon Ca2+ restitution to the bath in the continuous presence of
the agonist. (C) Mean ± SE of the amplitude of endogenous Ca2+ release and extracellular Ca2+ influx
induced by each concentration of AA. The asterisk indicates p < 0.05.
3.3. InsP3R3 and TPC1-2 Mediate AA-Induced Endogenous Ca2+ Release
Recent studies demonstrated that InsP3Rs and TPC1-2 mediate AA-induced endogenous Ca2+
release in human ECFCs [22] and rat pancreatic β cells [38]. Of note, a thorough characterization of their
Ca2+ toolkit disclosed that hCMEC/D3 cells express only one of the three InsP3R isoforms, i.e. InsP3R3,
and TPC1-2, while they lack InsP3R1-2 and RyR1-3 [17]. We first focused on the contribution of ER
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Ca2+ release through InsP3R3 to AA-induced intracellular Ca2+ release. As shown in Figure 4A, the
endogenous Ca2+ response to AA (30 µM) was abrogated by 2-aminoethoxydiphenyl borate (2-APB)
(50 µM, 20 min) (Figure 4B), which inhibits InsP3Rs under 0Ca2+ conditions [17,39], and by depletion of
the ER Ca2+ content with cyclopiazonic acid (CPA) (10 µM) (Figure 4C). As previously described [17],
CPA caused a transient elevation in [Ca2+]i by unmasking the passive ER Ca2+ leak followed by Ca2+
extrusion across the plasma membrane under 0Ca2+ conditions (Figure 4C). The following addition of
AA (30 µM) under these conditions failed to increase the [Ca2+]i, thereby confirming the role of ER
Ca2+ in AA-evoked intracellular Ca2+ response.
Next, we evaluated the contribution of lysosomal Ca2+ release through TPC1-2. The Ca2+ response
to AA (30 µM) was prevented upon disruption of the lysosomal Ca2+ pool with glycyl-L-phenylalanine
2-naphthylamide (GPN) (200 µM) administered under 0Ca2+ conditions (Figure 4D). In addition,
AA-evoked intracellular Ca2+ mobilization was suppressed by NED-19 (100 µM, 30 min) (Figure 4E),
which selectively blocks TPC1-2 [17,40]. The statistical analysis of these results is shown in Figure 4F.
In aggregate, these data provide the evidence that AA-evoked intracellular Ca2+ mobilization in
hCMEC/D3 cells is mediated by InsP3R3 and TPC1-2.
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Figure 4. Type 3 inositol-1,4,5-trisphosphate receptor 3 InsP3R3 and two-pore channels 1 and 2 
(TPC1-2) mediate endogenous Ca2+ release in response to arachidonic acid in hCMEC/D3 cells. (A) 
Endogenous Ca2+ mobilization induced by AA (30 μM) under 0Ca2+ conditions. (B) 
2-aminoethoxydiphenyl borate (2-APB; 50 μM, 30 min) prevents AA-evoked endogenous Ca2+ 
release. In this and in the following panels, AA has always been applied at 30 μM. (C) Cyclopiazonic 
acid (CPA; 10 μM) inhibited Sarco-Endoplasmic Reticulum Ca2+-ATPase (SERCA) activity, thereby 
eliciting a transient elevation in [Ca2+]i followed by Ca2+ removal from the cytosol. The following 
addition of AA did not result in an increase in [Ca2+]i. (D) Glycyl-L-phenylalanine 2-naphthylamide 
(GPN; 200 μM) elicited a transient elevation in [Ca2+]i due to the disruption of the lysosomal Ca2+ pool 
and the following liberation of lysosomal Ca2+ content into the cytosol [41,42]. The following addition 
of AA did not result in an increase in [Ca2+]i. (E) NED-19) (100 μM, 30 min) blocked AA-evoked 
intracellular Ca2+ release. (F) Mean ± SE of the amplitude of the intracellular Ca2+ response to AA 
under the designated treatments. The asterisk indicates p < 0.05. 
3.4. TRPV4 is Expressed and Mediates AA-Evoked Extracellular Ca2+ Influx 
TRPV4 is virtually the only Ca2+-permeable pathway responsible for AA-induced extracellular 
Ca2+ influx in endothelial cells [22,37,43,44]. Therefore, we first assessed whether a functional TRPV4 
protein was expressed in hCMEC/D3 cells. We carried out a Western Blot analysis by exploiting an 
affinity-purified antibody, which detected a major band at 91 kDa (Figure 5A), the expected 
molecular weight for TRPV4 [45]. Thereafter, we exposed hCMEC/D3 cells to GSK (20 nM), a specific 
TRPV4 agonist [45,46]. GSK (20 nM) caused a robust increase in [Ca2+]i in the presence, but not in the 
absence, of extracellular Ca2+ (Figure 5B), which is consistent with the notion that TRPV4 mediates 
extracellular Ca2+ influx. Notably, GSK-induced Ca2+ influx was suppressed by RN-1734 (20 μM, 20 
min), a selective TRPV4 blocker [45,47], in the majority of the cells, whereas it was remarkably 
inhibited in the remaining (Figure 5C,D). These preliminary experiments provide the evidence that 
TRPV4 is expressed and mediates extracellular Ca2+ influx in hCMEC/D3 cells.  
Figure 4. Type 3 inositol-1,4,5-trisphosphate receptor 3 InsP3R3 and two-pore channels 1 and 2 (TPC1-2)
mediate endogenous Ca2+ release in response o arachidonic acid in hCMEC/D3 cells. (A) Endogenous
Ca2+ mobilization i uc d by AA (30 µM) under 0Ca2+ conditions. (B) 2-aminoethoxydiphenyl
borate (2-APB; 50 µM, 30 min) prevents AA-evoked endogenous Ca2+ release. In this and in the
followi g panels, AA has always been applied at 30 µM. (C) Cyclopiazonic acid (CPA; 10 µM) inhibited
Sarco-Endoplasmic Re iculum Ca2+-ATPa e (SERCA) activity, thereby eliciting a transient elevation
in [Ca2+]i followed by Ca2+ removal from the cytosol. The following addition of AA did not r sult
in an i crease in [Ca2+]i. (D) Glycyl-L-phenylalanine 2-naphthylamide (GPN; 200 µM) elicited a
transient elevation in [Ca2+]i due to the disruption of the lysosomal Ca2+ pool and the following
liberation of lysosomal Ca2+ content into the cytosol [41,42]. The followi g addition of AA did n t
result in an increase in [Ca2+]i. (E) NED-19) (100 µM, 30 min) blocked AA-evoked intracellular Ca2+
release. (F) Mean ± SE of the amplitude of the intracellular Ca2+ response to AA under the designated
treatments. The asterisk indicates p < 0.05.
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3.4. TRPV4 is Expressed and Mediates AA-Evoked Extracellular Ca2+ Influx
TRPV4 is virtually the only Ca2+-permeable pathway responsible for AA-induced extracellular
Ca2+ influx in endothelial cells [22,37,43,44]. Therefore, we first assessed whether a functional TRPV4
protein was expressed in hCMEC/D3 cells. We carried out a Western Blot analysis by exploiting an
affinity-purified antibody, which detected a major band at 91 kDa (Figure 5A), the expected molecular
weight for TRPV4 [45]. Thereafter, we exposed hCMEC/D3 cells to GSK (20 nM), a specific TRPV4
agonist [45,46]. GSK (20 nM) caused a robust increase in [Ca2+]i in the presence, but not in the absence,
of extracellular Ca2+ (Figure 5B), which is consistent with the notion that TRPV4 mediates extracellular
Ca2+ influx. Notably, GSK-induced Ca2+ influx was suppressed by RN-1734 (20 µM, 20 min), a selective
TRPV4 blocker [45,47], in the majority of the cells, whereas it was remarkably inhibited in the remaining
(Figure 5C,D). These preliminary experiments provide the evidence that TRPV4 is expressed and
mediates extracellular Ca2+ influx in hCMEC/D3 cells.Cells 2019, 8,  9 of 20 
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previous reports in endothelial cells [22,37,43,44], the pharmacological blockade of TRPV4 with 
RN-1734 (20 μM, 20 min) decreased the magnitude and curtailed the duration of AA-evoked Ca2+ 
response (Figure 6A,B). To further confirm this observation, we assessed whether AA could increase 
the [Ca2+]i after exhaustion of the ER Ca2+ pool and full SOCE activation with CPA (10 μM) in the 
presence of extracellular Ca2+. Accordingly, SOCE is elicited by pharmacological depletion of the ER 
Ca2+ reservoir with CPA and can no longer be activated if ER cisternae are not replenished with Ca2+ 
because of CPA-dependent SERCA inhibition [17,48]. Therefore, under these conditions, any 
extracellular stimulation will be able to increase the [Ca2+]i only by mainly acting on 
store-independent Ca2+-permeable channels, such as TRPV4, located on the plasma membrane 
[22,24]. Accordingly, previous experiments revealed that AA did not evoke any Ca2+ signal under 
0Ca2+ conditions and following treatment with CPA (Figure 4C). Indeed, when AA (30 μM) was 
added upon SOCE activation with CPA (10 μM) for 30 min (early response to CPA not shown) in the 
presence of extracellular Ca2+, it elicited a sustained elevation in [Ca2+]i that was suppressed by 
RN-1734 (20 μM, 20 min) (Figure 6C,D). Therefore, these findings clearly show that TRPV4 mediates 
AA-induced Ca2+ influx in hCMEC/D3 cells. 
Figure 5. Transient Receptor Potential Vanilloid 4 (TRPV4) protein is expressed and mediates
extracellular Ca2+ influx in hCMEC/D3 cells. (A) Left, representative Western blots illustrating
TRPV4 and β-actin expression in HEK-293 cells (HEK) and hCMEC/D3 cells. Left, quantification of
TRPV4/β-actin protein levels in hCMEC/D3 cells normalized on HEK cells from three independent
experiments. (B) GSK1016790A (GSK; 20 nM) increased the [Ca2+]i in the presence, but not in the
absence (0Ca2+), of extracellular Ca2+. (C) RN-1734 (20 µM, 20 min) blocked GSK-evoked extracellular
Ca2+ influx. GSK was administered at 20 nM. (D) Mean ± SE of the amplitude of GSK-induced Ca2+
influx in the absence and in the presence of RN-1734 (RN). The total number of cells analysed in the
presence of RN is indicated in the brackets. The asterisk indicates p < 0.05.
Next, we explored the role of TRPV4 in AA-evoked intracellular Ca2+ signals. In agreement
with previous reports in endothelial cells [22,37,43,44], the pharmacological blockade of TRPV4 with
RN-1734 (20 µM, 20 min) decreased the magnitude and curtailed the duration of AA-evoked Ca2+
response (Figure 6A,B). To further confirm this observation, we assessed whether AA could increase
the [Ca2+]i after exhaustion of the ER Ca2+ pool and full SOCE activation with CPA (10 µM) in the
presence of extracellular Ca2+. Accordingly, SOCE is elicited by pharmacological depletion of the
ER Ca2+ reservoir with CPA and can no longer be activated if ER cisternae are not replenished with
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Ca2+ because of CPA-dependent SERCA inhibition [17,48]. Therefore, under these conditions, any
extracellular stimulation will be able to increase the [Ca2+]i only by mainly acting on store-independent
Ca2+-permeable channels, such as TRPV4, located on the plasma membrane [22,24]. Accordingly,
previous experiments revealed that AA did not evoke any Ca2+ signal under 0Ca2+ conditions and
following treatment with CPA (Figure 4C). Indeed, when AA (30 µM) was added upon SOCE activation
with CPA (10 µM) for 30 min (early response to CPA not shown) in the presence of extracellular
Ca2+, it elicited a sustained elevation in [Ca2+]i that was suppressed by RN-1734 (20 µM, 20 min)
(Figure 6C,D). Therefore, these findings clearly show that TRPV4 mediates AA-induced Ca2+ influx in
hCMEC/D3 cells.Cells 2019, 8, x 10 of 20 
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Figure 6. TRPV4 mediates arachidonic acid-induced extracellular Ca2+ influx in hCMEC/D3 cells. (A) 
Intracellular Ca2+ response to AA (30 μM) recorded in the presence and in the absence of RN-1734 (20 
μM, 20 min). (B) Mean ± SE of the amplitude of AA-evoked Ca2+ influx in the absence and in the 
presence of RN-1734 (RN). The asterisk indicates p < 0.05. (C) AA (30 μM) evoked an increase in the 
[Ca2+]i in the presence of extracellular Ca2+ upon 30 min treatment with CPA (10 μM) to deplete the 
ER Ca2+ store and fully activate store-operated Ca2+ influx (SOCE). AA-evoked Ca2+ influx was 
abolished by pretreating the cells with RN-1734 (20 μM, 20 min). (D) Mean ± SE of the amplitude of 
AA-induced intracellular Ca2+ signals in the absence and in the presence of RN-1734 (RN) upon 
SOCE activation with CPA (10 μM). The asterisk indicates p < 0.05. 
3.5. AA-Evoked Intracellular Ca2+ Signaling Drives NO Release in hCMEC/D3 Cells 
In order to assess whether AA-evoked Ca2+ signalling results in NO release, hCMEC/D3 cells 
were loaded with the NO-sensitive dye, DAF-FM, as illustrated in Section 2.3. Unlike the 
neurotransmitter acetylcholine [17], AA (30 μM) elicited a delayed increase in DAF-FM fluorescence 
that significantly lagged behind the onset of the Ca2+ signal (Figure 7A): accordingly, the NO signal 
arose with a latency of 149.4 ± 6.2 sec (n = 368) and slowly increased with a time-to-peak of 1230 ± 39 
sec (n = 339). AA-elicited NO release was abrogated by L-NG-Nitro-L-arginine methyl ester 
(L-NAME) (100 μM, 1 h) (Figure 7B), a widely employed NOS inhibitor [22,49], or 
1,2-Bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid tetrakis(acetoxymethyl ester) (BAPTA) 
(30 μM, 2 h) (Figure 7A), a membrane-permeant buffer of Ca2+ levels [22,49]. Notably, ETYA (30 μM) 
induced an increase in DAF-FM fluorescence whose kinetics and magnitude were again overlapping 
with those of the signal elicited by AA (30 μM) (Figure 7B). These data, therefore, indicate that 
AA-evoked Ca2+ signalling results in NO release also in hCMEC/D3 cells.  
Figure 6. TRPV4 mediates arachidonic acid-induced extracellular Ca2+ influx in hCMEC/D3 cells.
(A) Intracellular Ca2+ response to AA (30 µM) recorded in the presence and in the absence of RN-1734
(20 µM, 20 min). (B) Mean ± SE of the amplitude of AA-evoked Ca2+ influx in the absence and in the
presence of RN-1734 (RN). The asterisk indicates p < 0.05. (C) AA (30 µM) evoked an increase in the
[Ca2+]i in the presence of extracellular Ca2+ upon 30 min treatment with CPA (10 µM) to deplete the ER
Ca2+ store and fully activate store-operated Ca2+ influx (SOCE). AA-evoked Ca2+ influx was abolished
by pretreating the cells with RN-1734 (20 µM, 20 min). (D) Mean ± SE of the amplitude of AA-induced
intracellular Ca2+ signals in the absence and in the presence of RN-1734 (RN) upon SOCE activation
with CPA (10 µM). The asterisk indicates p < 0.05.
3.5. AA-Evoked Intracellular Ca2+ Signaling Drives NO Release in hCMEC/D3 Cells
In order to assess whether AA-evoked Ca2+ signalling results in NO release, hCMEC/D3 cells were
loaded with the NO-sensitive dye, DAF-FM, as illustrated in Section 2.3. Unlike the neurotransmitter
acetylch line [17], AA (30 µM) elicited a d layed incre se in DAF-FM fluoresc nce that significant y
lagg d behin the onset of the Ca2+ signal (Figure 7A): accordingly, he NO signal ar se with a latency of
149.4 ± 6.2 ec (n = 368) and slowly increased with a tim -to-peak of 1230 ± 39 sec (n = 339). AA- licited
NO release was abrogated by L-NG-Nitro-L-arginine methyl ester (L-N ME) (100 µM, 1 h) (Figure 7B),
widely employed NOS inhibitor [22,49], or 1,2-Bi (2-aminophenoxy)eth ne-N,N,N′,N′-tetraacetic
acid tetrakis(acetoxymethyl ester) (BAPTA) (30 µM, 2 h) (Figure 7A), a memb ane-p r ant buff
of Ca2+ levels [22,49]. Notably, ETYA (30 µM) induced an increase in DAF-FM fluorescence whose
kinet cs and magnitude were again overlapping with those of the signal elicited by AA (30 µM
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(Figure 7B). These data, therefore, indicate that AA-evoked Ca2+ signalling results in NO release also
in hCMEC/D3 cells.
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Figure 7. Arachidonic acid induces NO release in a Ca2+-dependent manner in hCMEC/D3 cells. (A) 
AA (20 μM) evoked a robust increase in the fluorescence in hCMEC/D3 cells loaded with the 
NO-selective fluorophore, 4-amino-5-methylamino-2’,7’-difluorofluorescein (DAF-FM). AA-elicited 
NO release was abrogated by L-NG-Nitro-L-arginine methyl ester (L-NAME; 100 μM, 1 h) or BAPTA 
(30 μM, 2 h). (B) Mean ± SE of the amplitude of AA-elicited NO release under the designated 
treatments. For L-NAME and BAPTA, the number of total cells analysed is indicated in the brackets. 
The asterisk indicates p < 0.05. (C) AA (30 μM) and ETYA (30 μM) induced an increase in DAF-FM 
fluorescence with overlapping kinetics and amplitude. (D) Mean ± SE of the amplitude of AA- and 
ETYA-evoked NO release in hCMEC/D3 cells. NR means no response. 
In order to dissect the contribution of extra- and intracellular Ca2+ sources to NO production, 
hCMEC/D3 cells were challenged with AA (30 μM) under 0Ca2+ conditions. Removal of external Ca2+ 
significantly (p < 0.05) reduced AA-elicited NO release, whereas restoration of extracellular Ca2+ 
levels caused a further elevation in DAF-FM fluorescence (Figure 8B). Accordingly, also the 
pharmacological blockage of TRPV4 with RN-1734 (20 μM, 30 min) remarkably impaired 
AA-elicited NO synthesis (Figure 8C). We adopted the same pharmacological strategy as that 
described in Section 3.3 to dissect the contribution of the ER and lysosomal Ca2+ stores to 
AA-induced NO release. Surprisingly, inhibition of InsP3R3 with 2-APB (50 μM, 20 min) (Figure 8D) 
and depletion of the ER Ca2+ store with CPA (10 μM, 30 min) (Figure 8E) did not affect the NO signal. 
Conversely, preventing lysosomal Ca2+ release through TPC1-2 with GPN (200 μM, 30 min) (Figure 
8F) and NED-19 (100 μM, 30 min) (Figure 8G) abolished AA-induced NO release. Altogether, these 
findings strongly suggest that TPC1-2 and TRPV4 are mainly responsible for the Ca2+-dependent 
recruitment of eNOS induced by AA in hCMEC/D3 cells. However, the slow kinetics of NO release 
are not compatible with a direct involvement of AA in NVC. 
Figure 7. Arachidonic acid induces NO release in a Ca2+-dependent manner in hCMEC/D3 cells.
(A) AA (20 µM) evoked a robust increase in the fluorescence in hCMEC/D3 cells loaded with the
NO-selective fluorophore, 4-amino-5-methylamino-2’,7’-difluorofluorescein (DAF-FM). AA-elicited
NO release was abrogated by L-NG-Nitro-L-arginine methyl ester (L-NAME; 100 µM, 1 h) or BAPTA
(30 µM, 2 h). (B) Mean ± SE of the amplitude of AA-elicited NO release under the designated treatments.
For L-NAME and BAPTA, the number of total cells analysed is indicated in the brackets. The asterisk
indicates p < 0.05. (C) AA (30 µM) and ETYA (30 µM) induced an increase in DAF-FM fluorescence
with overlapping kinetics and amplitude. (D) Mean ± SE of the amplitude of AA- and ETYA-evoked
NO release in hCMEC/D3 cells. NR means no response.
In order to dissect the contribution of extra- and intracellular Ca2+ sources to NO production,
hCMEC/D3 cells were challenged with AA (30 µM) under 0Ca2+ conditions. Removal of external Ca2+
significantly (p < 0.05) reduced AA-elicited NO release, whereas restoration of extracellular Ca2+ levels
caused a further elevation in DAF-FM fluorescence (Figure 8B). Accordingly, also the pharmacological
blockage of TRPV4 with RN-1734 (20 µM, 30 min) remarkably impaired AA-elicited NO synthesis
(Figure 8C). We adopted the same pharmacological strategy as that described in Section 3.3 to dissect the
contribution of the ER and lysosomal Ca2+ stores to AA-induced NO release. Surprisingly, inhibition
of InsP3R3 with 2-APB (50 µM, 20 min) (Figure 8D) and depletion of the ER Ca2+ store with CPA
(10 µM, 30 min) (Figure 8E) did not affect the NO signal. Conversely, preventing lysosomal Ca2+ release
through TPC1-2 with GPN (200 µM, 30 min) (Figure 8F) and NED-19 (100 µM, 30 min) (Figure 8G)
abolished AA-induced NO release. Altogether, these findings strongly suggest that TPC1-2 and TRPV4
are mainly responsible for the Ca2+-dependent recruitment of eNOS induced by AA in hCMEC/D3
cells. However, the slow kinetics of NO release are not compatible with a direct involvement of AA
in NVC.
Cells 2019, 8, 689 11 of 18Cells 2019, 8, x 12 of 20 
 
0 500 1000 1500 2000 2500
0.35
0.40
0.45
0.50
0.55 AA 30 μM
Time (sec)
NO
i (F
53
5)
0 400 800 1200 1600
0.4
0.5
0.6 Ca2+ Ca2+
0Ca2+
AA 30 μM
Time (sec)
NO
i (F
53
5)
0 500 1000 1500
0.40
0.45
0.50
0.55
RN-1734 20 μM
AA 30 μM
Time (sec)
NO
i (F
53
5)
0 500 1000 1500
0.35
0.40
0.45
0.50
0.55 AA 30 μM
2-APB 50 μM
Time (sec)
NO
i (F
53
5)
0 400 800 1200 1600 2000 2400 2800
0.35
0.40
0.45
0.50
0.55
AA 30 μM
CPA 10 μM
Time (sec)
NO
i (F
53
5)
0 200 400 600 800 1000
0.40
0.45
0.50
0.55 AA 30 μM
GPN 200 μM
Time (sec)
NO
i (F
53
5)
0 400 800 1200 1600
0.35
0.40
0.45
0.50
0.55 AA 30 μM
NED-19 100 μM
Time (sec)
NO
i (F
53
5)
Ctr
l
0Ca RN2-A
PB CP
A
NE
D-1
9 
GP
N
0.00
0.05
0.10
0.15
Pe
ak
 ( Δ
DA
F-
FM
)
150
81
(121) 56(133)
133 79
82
(181) 104
(220)
*
* *
*
A B
C D
E F
G H
 
Figure 8. TPC1-2 and TRPV4 support arachidonic acid-induced NO production in hCMEC/D3 cells. 
(A) AA (30 μM) evoked robust NO release under control conditions in hCMEC/D3 cells. (B) AA (30 
μM) induced NO release under 0Ca2+ conditions, although this signal was lower as compared to 
control conditions. However, readdition of Ca2+ to the perfusate caused a second increase in DAF-FM 
fluorescence. (C) RN-1734 (20 μM, 20 min) reduced AA-evoked NO release. AA was administered at 
30 μM. (D) 2-APB (50 μM, 30 min) did not affect AA-induced NO production. AA was administered 
at 30 μM. (E) CPA (10 μM, 30 min) did not impair AA-evoked NO release. AA was administered at 
30 μM. (F) GPN (200 μM, 30 min) remarkably reduced AA-induced NO production. AA was 
administered at 30 μM. (G) NED-19 (100 μM, 30 min) impaired AA-evoked NO release. AA was 
administered at 30 μM. (H) Mean ± SE of the amplitude of AA-evoked NO release under the 
designated treatments. The asterisk indicates p < 0.05. The total number of analysed cells is indicated 
in the brackets. 
4. Discussion 
Herein, we demonstrate for the first time that the conditionally essential PUFA AA is able to 
elicit NO release from a human brain microvascular endothelial cell line in a Ca2+-dependent 
manner. The Ca2+ response to AA involves endogenous Ca2+ release from the ER and lysosomal Ca2+ 
pools through, respectively, InsP3R3 and TPC1-2 and extracellular Ca2+ influx through TRPV4. 
However, only TPC1-2 channels and TRPV4 are seemingly coupled to eNOS activation and NO 
release. AA is the precursor of multiple vasoactive mediators shaping the hemodynamic response to 
Figure 8. TPC1-2 and TRPV4 support arachidonic acid-induced NO production in hCMEC/D3 cells.
(A) AA (30 µM) evoked robust NO release under control conditions in hCMEC/D3 cells. (B) AA
(30 µM) induced NO release under 0Ca2+ conditions, although this signal was lower as compared to
control conditions. However, readdition of Ca2+ to the perfusate caused a second increase in DAF-FM
fluorescence. (C) RN-1734 (20 µM, 20 min) reduced AA-evoked NO release. AA was administered at
30 µM. (D) 2-APB (50 µM, 30 min) did not affect AA-induced NO production. AA was administered at
30 µM. (E) CPA (10 µM, 30 min) did not impair AA-evoked NO release. AA was administered at 30 µM.
(F) GPN (200 µM, 30 min) remarkably reduced AA-induced NO production. AA was administered
at 30 µ . (G) NED-19 (100 µM, 30 min) i paired AA-evoked NO release. AA was administered at
30 µM. (H) Mean ± SE of the amplitude of AA-evoked NO release under the designated treatments.
The asterisk indicates p < 0.05. The total number of analysed cells is indicated in the brackets.
4. Discussion
Herein, we demonstrate for the first time that the conditionally essential PUFA AA is able to elicit
NO release from a human brain microvascular endothelial cell line in a Ca2+-dependent manner. The
Ca2+ response to AA involves ndogenous Ca2+ rele se from the ER and ly osom l Ca2+ pools through,
respectively, InsP3R3 and TPC1-2 d extracellular Ca2+ influx through TRPV4. However, only TPC1-2
chan els and TRPV4 are seemingly coupled to eNOS activation and NO elease. AA is the precursor of
multiple vasoactive m diators shaping the hemodynamic respons to neuronal activity. However, the
slow kin tics of AA-evoked NO release make it unlik ly that this signal directly contribu es to NVC.
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4.1. Intracellular Ca2+ Signals Induced by AA in hCMEC/D3 Cells
It has long been known that synaptic activity leads to a significant increase in the local AA
concentration, which can raise up to 50–200 µM following the Ca2+-dependent recruitment of PLA2 in
both postsynaptic neurons and perisynaptic astrocytes [29–31]. AA, in turn, regulates multiple synaptic
processes, including neurotransmitter release [50], long-term potentiation [29,30], and local increase in
CBF [2,7]. Intriguingly, a recent investigation demonstrated that 50 µM AA could elicit an increase in
[Ca2+]i in primary human brain endothelial cells [23]. As endothelial Ca2+ signals are emerging as
an unsuspected regulator of NVC [11,12,14,17,51] and AA may directly trigger Ca2+-dependent NO
release in other endothelial cell types [18–22], we sought to assess whether it could elicit intracellular
Ca2+ signals and NO release also in human cerebrovascular endothelial cells [15].
4.2. The Dose–Response Relationship of AA-Evoked Intracellular Ca2+ Signals in hCMEC/D3 Cells
We found that AA induced a dose-dependent increase in [Ca2+]i within the physiological
concentration range that it reaches during synaptic activity. The EC50 of AA-evoked Ca2+ signal was
indeed 8.4 µM, whereas the peak Ca2+ response was attained at 300 µM. A similar analysis revealed
that breast tumor-derived endothelial cells (b-TECs) displayed a higher sensitivity as compared to
hCMEC/D3 cells, as the Ca2+ response to AA arose at 0.5 µM and achieved its peak at 10 µM [37].
However, AA-evoked Ca2+ signals in ECFCs appeared at concentrations higher than 2 µM and attained
the maximal amplitude at 100 µM [22,45]. Likewise, a sizeable elevation in [Ca2+]i was detected in
human umbilical vein endothelial cells (HUVECs) challenged with 10–40 µM AA [36]. The endothelial
Ca2+ response to AA can, however, be induced by many of its metabolites. For instance, 5,6-EET
and 8,9-EET mediate AA-evoked Ca2+ response in mouse aortic endothelial cells [32,33], whereas
leukotriene C4 is responsible for AA-induced Ca2+ influx in HUVECs [36]. Nevertheless, ETYA,
a non-metabolizable analogue of AA, evoked an increase in in [Ca2+]i in hCMEC/D3 cells whose
magnitude and kinetics were similar to those induced by AA, as also observed in bovine aortic
endothelial cells [21], b-TECs [37] and ECFCs [22]. It is, therefore, possible to conclude that AA directly
induces intracellular Ca2+ signalling in hCMEC/D3 cells.
4.3. The Complex Mechanism of AA-Evoked Intracellular Ca2+ Signals in hCMEC/D3 Cells: InsP3R3, TPC1-2,
and TRPV4
A wide repertoire of mechanisms may be exploited by AA to increase the [Ca2+]i in endothelial
cells. For instance, the Ca2+ response to AA is mediated by intracellular Ca2+ release through InsP3Rs
and TPCs and by extracellular Ca2+ influx through TRPV4 in ECFCs [22], whereas TRPV4 mediates
AA-evoked Ca2+ signals in b-TECs [43], mouse aortic [32,33] and pulmonary artery [35] endothelial
cells. A preliminary report showed that AA induced both endogenous Ca2+ release and extracellular
Ca2+ influx in primary human brain microvascular endothelial cells. This investigation suggested
the involvement of ER Ca2+ release through InsP3Rs, but some Ca2+ mobilization still occurred in
the presence of 2-APB. Furthermore, the pathway responsible for extracellular Ca2+ influx was not
evaluated [23].
4.3.1. InsP3R3 and TPC1-2
Herein, manipulation of extracellular Ca2+ levels revealed that the Ca2+ response to AA in
hCMEC/D3 cells required both intra- and extracellular Ca2+ sources. AA-evoked Ca2+ release was
strongly impaired by preventing InsP3R3-dependent ER Ca2+ mobilization with 2-APB and CPA.
In agreement with these observations, it has beed demonstrated that AA directly activates InsP3Rs in
several cellular types [52–54]. Besides the ER Ca2+ pool, AA is capable of mobilizing lysosomal Ca2+
through the recently identified TPC1-2, as demonstrated in rat pancreatic β-cells [38] and ECFCs [22].
Accordingly, AA-evoked intracellular Ca2+ release was impaired by disrupting the lysosomal Ca2+
reservoir with GPN and by blocking TPC1-2 with NED-19. It is not clear how AA induces lysosomal
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Ca2+ release in hCMEC/D3 cells. It has recently been demonstrated that a remarkable Ca2+-mediated
cross-talk is established between the ER and lysosomal Ca2+ pools [55–57]. For instance, the ER Ca2+
mobilized by InsP3 may be directly transferred into the acidic vesicles at ER-lysosome contact sites,
thereby increasing the lysosomal Ca2+ content [58]. An increase in intraluminal Ca2+ could in turn
activate TPC2 and, sometimes, also TPC1 [40]. An alternative hypothesis, which does not rule out the
previous one, implies that InsP3-dependent Ca2+ release stimulates the Ca2+-dependent production of
nicotinic acid adenine dinucleotide phosphate (NAADP), the physiological agonist of TPCs [40,59].
Finally, TPC1-2 could trigger InsP3-dependent Ca2+ release from the ER through the Ca2+-induced
Ca2+ release process [60,61]. Whatever the interaction mode, it is clear that both InsP3R3 and TPC1-2
contribute to AA-evoked intracellular Ca2+ release in hCMEC/D3 cells.
4.3.2. TRPV4
As for extracellular Ca2+ influx, the available evidence hints at the involvement of TRPV4. First,
a functional TRPV4 protein is expressed in these cells, as testified by Western Blot analysis and the Ca2+
response to GSK, a selective TRPV4 agonist [47]. In addition, GSK was found to induce exclusively
extracellular Ca2+ influx and its action was inhibited by RN-1734, a specific TRPV4 blocker. Second,
RN-1734 mimicked extracellular Ca2+ removal, by reducing the amplitude and curtailing the Ca2+
response to AA. Third, AA was still able to induce RN-1734-sensitive Ca2+ influx upon full activation
of SOCE, which represents an alternative pathway for Ca2+ influx in hCMEC/D3 cells [17]. In addition,
AA has long been known to inhibit [18,22,24,25], rather than inducing, SOCE. Finally, Orai3, which is
expressed in hCMEC/D3 cells [17] and mediates AA-induced extracellular Ca2+ influx in HUVECs [36]
and rat carotid artery vascular smooth muscle cells [62], is not directly gated by AA, but by leukotriene
C4. Conversely, extracellular Ca2+ influx in hCMEC/D3 cells is not promoted by AA metabolites (see
Paragraph 4.1). There is, therefore, strong evidence to support the conclusion that TRPV4 is responsible
for AA-induced Ca2+ influx in hCMEC/D3 cells.
4.4. AA Induces NO Release in hCMEC/D3 Cells: The Rationale for the Present Investigation
The physiological role of AA metabolites in NVC has recently been extensively reviewed [2,7].
It has been largely accepted that neuronal activity leads to PGE2 synthesis via COX-2 and COX-1 in
neurons and astrocytes, respectively, to EET production via cytochrome P450 epoxygenase in glial
cells, and 20-HETE synthesis in VSMCs and pericytes via cytochrome P450 4A2 [2,4–6]. Intriguingly,
the vasomotor effect of AA metabolites is finely tuned by NO, which suppresses 20-HETE formation,
thereby enabling PGE2-dependent vasodilation in the somatosensory cortex [9] and the molecular layer
of the cerebellum [63]. It has, however, long been known that the pharmacological blockade of all the
signalling pathways leading to an increase in CBF, i.e., NO, PGE2, EET, and K+ signalling, does not lead
to a complete inhibition of the hemodynamic response [4]. While the molecular mechanisms driving
CBF may vary along the cerebrovascular tree, the signalling mechanisms of NVC could be highly
redundant in order to ensure proper blood supply to the working brain [64]. Quite unexpectedly [4], it
has been recently demonstrated that the hemodynamic response may be initiated at capillary level
by various mechanisms [5,10,63], including the endothelial cell ability to detect neuronal activity [13].
In addition, synaptic activity was found to induce NO-mediated vasorelaxation in penetrating arterioles
and capillaries through the activation of endothelial NMDARs [11]. These in vivo findings were
confirmed by the evidence, provided in vitro, that glutamate and acetylcholine were able to induce
repetitive Ca2+ transients in mouse brain endothelial cells [14,16]. Likewise, acetylcholine-induced
intracellular Ca2+ signals and NO release were reported in hCMEC/D3 cells [17].
4.4.1. AA Induces Delayed NO Release in hCMEC/D3 Cells
As it has long been known that AA directly induces Ca2+-dependent NO release throughout
peripheral circulation [18,65] and in ECFCs [22], which represent the only known truly endothelial
precursors in flowing blood [66], we reasoned it was worth assessing whether this mechanism was at
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work also in brain microvascular endothelial cells. However, NO release started with a significantly
longer latency (~150 sec) as compared to the onset of the Ca2+ signal, which was immediate. The delayed
kinetics of the increase in DAF-FM noted in response to AA are similar to observations in mouse
brain microvascular endothelial cells challenged with glutamate [14]. As discussed elsewhere [5,14,67],
DAF-FM does not truly detect NO, but it rather reacts with multiple nitrogen derivatives, including
ONOO, NO2, and N2O3. We cannot, therefore, rule out the hypothesis that the NO signal arises before
the increase in DAF-FM fluorescence is detectable by our imaging system. Yet, it seems unlikely that
such a delayed NO release may induce the rapid increase in CBF that follows neuronal activity with a
latency of ~600 msec [68]. So, it is conceivable that the major role of AA-induced NO release from
human cerebrovascular endothelial cell is other than controlling NVC. Early studies demonstrated that
AA-dependent NO release stimulated angiogenesis in different types of endothelial cells, including
bovine aortic endothelial cells [18], b-TECs [19,43], and ECFCs [22]. Of note, AA promotes proliferation
and migration also in rat brain microvascular endothelial cells [69,70]. Future investigation is required
to assess whether AA-induced NO production also stimulates angiogenesis in hCMEC/D3 cells.
4.4.2. AA Induced NO Release via TPC1-2 and TRPV4 in hCMEC/D3 Cells
The mechanism whereby AA induces NO release in hCMEC/D3 cells is, however, somehow
different from that reported in other endothelial cell types. For instance, TRPV4 provides the source of
Ca2+ necessary for AA-dependent recruitment of eNOS in b-TECs [19,43], while TRPV4 is supported by
InsP3Rs and TPC1 in ECFCs [22]. Herein, we found that AA-evoked NO production in hCMEC/D3 cells
was mainly driven by TPC1-2 and TRPV4 channels. Accordingly, the increase in DAF-FM fluorescence
induced by AA was significantly reduced both by removal of extracellular Ca2+ and by pharmacological
blockade of TRPV4 with RN-1734. Likewise, the impairment of lysosomal Ca2+ mobilization with
GPN, which disrupts acidic vesicles, or NED-19, which blocks TPC1-2, suppressed AA-evoked NO
release in hCMEC/D3 cells. These observations support the emerging role of lysosomal Ca2+ release in
driving eNOS activation throughout vascular endothelium: TPC1 and/or TPC2 were indeed found to
stimulate NO production in human and rat aortic endothelial cells [71], mouse [14] and human [17]
brain microvascular endothelial cells, and ECFCs [22]. Conversely, preventing InsP3-dependent ER
Ca2+ release with 2-APB, which inhibits InsP3R3, or with CPA, which depletes the ER Ca2+ store [17],
did not significantly affect eNOS activation by AA. This result was somehow unexpected as InsP3R3
supports acetylcholine-induced NO production in hCMEC/D3 cells [17]. It is, therefore, conceivable
that the pool of ER-embedded InsP3R3 is not coupled to eNOS.
5. Conclusions
We provided the first evidence that AA, whose metabolites are known to modulate CBF, is per se
able to induce Ca2+-dependent NO release in a human cerebrovascular endothelial cell line. The Ca2+
response to AA requires endogenous Ca2+ release through ER-embedded InsP3R3 and lysosomal
TPC1-2 and extracellular Ca2+ influx through TRPV4. However, only TPC1-2 and TRPV4 drive NO
production, while InsP3R3 plays no sizeable role in this signal. This finding suggests that, besides being
metabolized into the vasorelaxing mediators PGE2 and EETs, AA could induce NO release from human
brain microvascular endothelial cells. It is, however, unlikely that AA-induced endothelial-dependent
NO release is directly involved in the onset of the hemodynamic response to neuronal activity. These
findings should, however, be confirmed in vivo by taking advantage of the availability of mouse
models expressing endothelial genetic Ca2+ indicators [72]. However, a recent report confirmed that
acetylcholine was able to induce endothelial NO release in vivo [73], as suggested by previous in vitro
observations in hCMEC/D3 cells [17]. This same report provided the evidence that also synaptically
released glutamate induced endothelial NO production [73], as previously observed in a mouse brain
cerebrovascular endothelial cell line [14].
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